Omega Fund Management’s Checkmate Pharmaceuticals, Inc. Common Stock CMPI Stock Holding History

Omega Fund Management’s Portfolio CMPI Stock Details CMPI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-1,335,050	Closed	-$4.26M	–	23
2022 Q1	$4.26M	Hold	1,335,050	–	–	0.87%	17
2021 Q4	$3.83M	Hold	1,335,050	–	–	0.54%	20
2021 Q3	$5.3M	Hold	1,335,050	–	–	0.59%	18
2021 Q2	$7.96M	Hold	1,335,050	–	–	0.9%	16
2021 Q1	$16.2M	Hold	1,335,050	–	–	1.53%	13
2020 Q4	$19.5M	Hold	1,335,050	–	–	2.92%	8
2020 Q3	$15.4M	Buy	+1,335,050	New	+$17.1M	4.16%	6

Omega Fund Management's CMPI Position: Q2 2022 in Review

Omega Fund Management sold out of Checkmate Pharmaceuticals, Inc. Common Stock (CMPI) in Q2 2022, closing a stake of 1,335,050 shares — an estimated $4.26M sold.

Omega Fund Management first reported a position in CMPI in Q3 2020 and held it in 7 quarters. The position peaked at $19.5M in Q4 2020. 0 funds tracked by Wall St. Rank hold CMPI as of Q2 2022.

Omega Fund Management reported no remaining Checkmate Pharmaceuticals, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
Omega Fund Management sold 1,335,050 Checkmate Pharmaceuticals, Inc. Common Stock shares in Q2 2022, an estimated $4.26M.
Omega Fund Management first reported a position in Checkmate Pharmaceuticals, Inc. Common Stock in Q3 2020 and held it in 7 quarters.
Omega Fund Management's Checkmate Pharmaceuticals, Inc. Common Stock position peaked at $19.5M in Q4 2020.
0 funds tracked by Wall St. Rank held Checkmate Pharmaceuticals, Inc. Common Stock as of Q2 2022.

Based on Omega Fund Management's 13F filing for Q2 2022, filed 15 Aug 2022.